| 今开:4.81 | 昨收:4.81 |
| 最高:4.84 | 最低:4.525 |
| 涨停价:0.0 | 跌停价:0.0 |
| 总市值:2.82163405E8 |
OYang10-28 19:28
#药闻简讯# $Aldeyra Therapeutics(ALDX)$ 宣布酒精性肝炎二期临床试验结果积极,聚焦下一代分子 RASP 产品候选管线
相对于基线,用于酒精相关肝病的信号发现分子 ADX‑629 在肝功能方面显示出统计学上的显著改善
ADX-629,一种用于概念验证临床试验的信号发现 RASP 调节剂,在一项针对四...查看全文
OYang08-28 22:22
#药闻简讯# $Aldeyra Therapeutics(ALDX)$ 获得欧洲药品管理局对 ADX-2191 用于治疗免疫特权部位原发性大 B 细胞淋巴瘤的孤儿药认定,包括原发性视网膜脉络膜淋巴瘤查看全文
Aldeyra Therapeutics(ALDX)08-16 04:15
$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-109391 Size: 4 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)11-06 05:25
$Aldeyra Therapeutics(ALDX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-266989 Act: 34 Size: 8 MB 网页链接查看全文
Aldeyra Therapeutics(ALDX)08-14 06:05
$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-108210 Size: 5 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)08-15 04:35
$Aldeyra Therapeutics(ALDX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000950170-25-108920 Act: 34 Size: 10 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)08-19 19:05
$Aldeyra Therapeutics(ALDX)$ 8-K Current report, item 9.01 Accession Number: 0000950170-25-109932 Act: 34 Size: 275 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)08-13 05:55
$Aldeyra Therapeutics(ALDX)$ 144 Report of proposed sale of securities Accession Number: 0001836354-25-000003 Act: 33 Size: 4 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)10-28 19:05
$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-25-252200 Act: 34 Size: 486 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)2019-12-26 22:46
【异动】$Aldeyra Therapeutics(ALDX)$ 22:46涨幅达7.04%,现价6.08美元查看全文
Aldeyra Therapeutics(ALDX)2019-12-26 22:40
【异动】$Aldeyra Therapeutics(ALDX)$ 22:40涨幅达4.08%,现价5.91美元查看全文
Aldeyra Therapeutics(ALDX)2019-12-18 20:45
$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-19-029509 Size: 4 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)2019-12-18 20:45
$Aldeyra Therapeutics(ALDX)$ 内部交易: 2019-12-16,总裁 and CEO,Brady Todd C ,买入,20000普通股, $5.10查看全文
狂拉的麦克斯2019-12-03 22:21
$Aldeyra Therapeutics(ALDX)$ Thinly traded micro cap Aldeyra Therapeutics (NASDAQ:ALDX) slumps premarket on increased volume in response to results from the first phase of a two-part Phase 3 clinical trial, RENEW, evaluating topical ophthalmic solution reproxalap, an aldehyde...查看全文
Aldeyra Therapeutics(ALDX)2019-12-03 20:45
$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-19-304808 Act: 34 Size: 8 MB 网页链接查看全文
牛唐2019-11-28 15:37
$Aldeyra Therapeutics(ALDX)$ 三天23%的收益,提前知道交易计划,请查看雪球号介绍内容。
$恒瑞医药(SH600276)$ $北大医药(SZ000788)$查看全文
牛唐2019-11-23 21:54
$Aldeyra Therapeutics(ALDX)$ 催化剂突然提前准备公布,向好概率较大,之前5.2以下建仓的朋友要守住。
$虎牙(HUYA)$ $爱奇艺(IQ)$查看全文
Aldeyra Therapeutics(ALDX)2019-11-08 08:40
$Aldeyra Therapeutics(ALDX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-11-07 AccNo: 0001564590-19-041846 Size: 5 MB 网页链接查看全文
一、开场介绍
会议时间: 未明确提及具体日期
主持人说明:
会议为HC Wainwright全球投资会议,由该公司资深生物技术分析师Matthew Caufield主持,目的是与Aldeyra Therapeutics公司CEO Todd Brady讨论公司管线进展。
管理层发言摘要:
Todd Brady(CEO):重点介绍了公司主要候...
一、开场介绍
会议时间: H.C. Wainwright第五届年度眼科会议
主持人说明:
Matthew Caufield介绍会议目的,欢迎Aldeyra Therapeutics首席执行官Todd Brady博士参与讨论。
管理层发言摘要:
Todd Brady强调公司从眼科起步的免疫学平台定位,重点介绍RASP(活性醛类物质)调节技...
$Aldeyra Therapeutics(ALDX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-266989 Act: 34 Size: 8 MB 网页链接
$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-25-252200 Act: 34 Size: 486 KB 网页链接
$Aldeyra Therapeutics(ALDX)$ 8-K Current report, item 9.01 Accession Number: 0000950170-25-109932 Act: 34 Size: 275 KB 网页链接
$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-109391 Size: 4 KB 网页链接
$Aldeyra Therapeutics(ALDX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000950170-25-108920 Act: 34 Size: 10 KB 网页链接
$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-108210 Size: 5 KB 网页链接
$Aldeyra Therapeutics(ALDX)$ 144 Report of proposed sale of securities Accession Number: 0001836354-25-000003 Act: 33 Size: 4 KB 网页链接
$Aldeyra Therapeutics(ALDX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-25-104971 Act: 34 Size: 8 MB 网页链接
$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001213900-25-064869 Act: 34 Size: 217 KB 网页链接
$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001213900-25-058035 Act: 34 Size: 232 KB 网页链接